Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study - PubMed (original) (raw)
Multicenter Study
. 2001 Mar 1;32(5):701-7.
doi: 10.1086/319222. Epub 2001 Feb 28.
Affiliations
- PMID: 11229837
- DOI: 10.1086/319222
Free article
Multicenter Study
Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study
P L Ho et al. Clin Infect Dis. 2001.
Free article
Abstract
A case-control study was conducted to identify the risk factors associated with levofloxacin-resistant Streptococcus pneumoniae (LRSP) colonization or infection. Twenty-seven case patients (patients with LRSP) were compared with 54 controls (patients with levofloxacin-susceptible S. pneumoniae). Risk factors that were significantly associated with LRSP colonization or infection, according to univariate analysis, included an older age (median age, 75 years for case patients versus 72.5 years for controls), residence in a nursing home (odds ratio [OR], 7.2), history of recent (OR, 4.6) and multiple (OR, 4.4) hospitalizations, prior exposure to fluoroquinolones (OR, 10.6) and beta-lactams (OR, 8.6), presence of chronic obstructive pulmonary disease (COPD; OR, 5.9), and nosocomial origin of the bacteria (OR, 5.7). Multivariate analysis showed that presence of COPD (OR, 10.3), nosocomial origin of the bacteria (OR, 16.2), residence in a nursing home (OR, 7.4), and exposure to fluoroquinolones (OR, 10.7) were independently associated with LRSP colonization or infection. Thus, a distinct group of patients with COPD is the reservoir of LRSP.
Similar articles
- Fatal meningitis due to levofloxacin-resistant Streptococcus pneumoniae.
Wortmann GW, Bennett SP. Wortmann GW, et al. Clin Infect Dis. 1999 Dec;29(6):1599-600. doi: 10.1086/313557. Clin Infect Dis. 1999. PMID: 10585837 No abstract available. - A nosocomial outbreak of fluoroquinolone-resistant Streptococcus pneumoniae.
Weiss K, Restieri C, Gauthier R, Laverdière M, McGeer A, Davidson RJ, Kilburn L, Bast DJ, de Azavedo J, Low DE. Weiss K, et al. Clin Infect Dis. 2001 Aug 15;33(4):517-22. doi: 10.1086/322658. Epub 2001 Jul 20. Clin Infect Dis. 2001. PMID: 11462189 - Longitudinally tracking fluoroquinolone resistance and its determinants in penicillin-susceptible and -nonsusceptible Streptococcus pneumoniae isolates in Hong Kong, 2000 to 2005.
Ip M, Chau SS, Chi F, Cheuk ES, Ma H, Lai RW, Chan PK. Ip M, et al. Antimicrob Agents Chemother. 2007 Jun;51(6):2192-4. doi: 10.1128/AAC.00139-07. Epub 2007 Mar 19. Antimicrob Agents Chemother. 2007. PMID: 17371818 Free PMC article. - Resistance of Streptococcus pneumoniae to fluoroquinolones--United States, 1995-1999.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2001 Sep 21;50(37):800-4. MMWR Morb Mortal Wkly Rep. 2001. PMID: 11785571 - A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance.
Fuller JD, Low DE. Fuller JD, et al. Clin Infect Dis. 2005 Jul 1;41(1):118-21. doi: 10.1086/430829. Epub 2005 May 26. Clin Infect Dis. 2005. PMID: 15937772 Review.
Cited by
- [Guidelines for the management of community pneumonia in adult who needs hospitalization].
Álvarez-Rocha L, Alós JI, Blanquer J, Álvarez-Lerma F, Garau J, Guerrero A, Torres A, Cobo J, Jordá R, Menéndez R, Olaechea P, Rodríguez de Castro F; Grupo de Estudio de la Neumonía Comunitaria Grave. Álvarez-Rocha L, et al. Med Intensiva. 2005 Feb;29(1):21-62. doi: 10.1016/S0210-5691(05)74199-1. Epub 2009 Jan 6. Med Intensiva. 2005. PMID: 38620135 Free PMC article. Spanish. - Updates on community acquired pneumonia management in the ICU.
Nair GB, Niederman MS. Nair GB, et al. Pharmacol Ther. 2021 Jan;217:107663. doi: 10.1016/j.pharmthera.2020.107663. Epub 2020 Aug 15. Pharmacol Ther. 2021. PMID: 32805298 Free PMC article. Review. - A prescription event monitoring study on the utility of garenoxacin, a newer fluoroquinolone in India.
Hajare A, Gupta A, Patil S, Krishnaprasad K, Bhargava A. Hajare A, et al. Int J Appl Basic Med Res. 2015 May-Aug;5(2):87-91. doi: 10.4103/2229-516X.157151. Int J Appl Basic Med Res. 2015. PMID: 26097813 Free PMC article. - Clinical importance and epidemiology of quinolone resistance.
Kim ES, Hooper DC. Kim ES, et al. Infect Chemother. 2014 Dec;46(4):226-38. doi: 10.3947/ic.2014.46.4.226. Epub 2014 Dec 29. Infect Chemother. 2014. PMID: 25566402 Free PMC article. Review. - Efficacy and safety of levofloxacin in the context of other contemporary fluoroquinolones: a review.
Ball P. Ball P. Curr Ther Res Clin Exp. 2003 Nov;64(9):646-61. doi: 10.1016/j.curtheres.2003.11.003. Curr Ther Res Clin Exp. 2003. PMID: 24944413 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical